Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2014; 47(03): 318-324
DOI: 10.4103/0970-0358.146578
Original Article
Association of Plastic Surgeons of India

Evaluation of lymphangiogenesis in acellular dermal matrix

Mario Cherubino
Division of Plastic and Reconstructive Surgery, Circolo Hospital and Macchi Fundation, University of Insubria, Varese, 21100, Viale Borri 57 Italy
,
Igor Pellegatta
Division of Plastic and Reconstructive Surgery, Circolo Hospital and Macchi Fundation, University of Insubria, Varese, 21100, Viale Borri 57 Italy
,
Federico Tamborini
Division of Plastic and Reconstructive Surgery, Circolo Hospital and Macchi Fundation, University of Insubria, Varese, 21100, Viale Borri 57 Italy
,
Michele Cerati
1   Division of Anatomopatology, University of Insubria, Circolo Hospital and Macchi Fundation, Varese, Italy
,
Fausto Sessa
1   Division of Anatomopatology, University of Insubria, Circolo Hospital and Macchi Fundation, Varese, Italy
,
Luigi Valdatta
1   Division of Anatomopatology, University of Insubria, Circolo Hospital and Macchi Fundation, Varese, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
26 August 2019 (online)

Also available at
   Permissions and Reprints

ABSTRACT

Introduction: Much attention has been directed towards understanding the phenomena of angiogenesis and lymphangiogenesis in wound healing. Thanks to the manifold dermal substitute available nowadays, wound treatment has improved greatly. Many studies have been published about angiogenesis and cell invasion in INTEGRA®. On the other hand, the development of the lymphatic network in acellular dermal matrix (ADM) is a more obscure matter. In this article, we aim to characterize the different phases of host cell invasion in ADM. Special attention was given to lymphangiogenic aspects. Materials and Methods: Among 57 rats selected to analyse the role of ADM in lymphangiogenesis, we created four groups. We performed an excision procedure on both thighs of these rats: On the left one we did not perform any action except repairing the borders of the wound; while on the right one we used INTEGRA® implant. The excision biopsy was performed at four different times: First group after 7 days, second after 14 days, third after 21 days and fourth after 28 days. For our microscopic evaluation, we used the classical staining technique of haematoxylin and eosin and a semi-quantitative method in order to evaluate cellularity counts. To assess angiogenesis and lymphangiogenesis development we employed PROX-1 Ab and CD31/PECAM for immunohistochemical analysis. Results: We found remarkable wound contraction in defects that healed by secondary intention while minor wound contraction was observed in defects treated with ADM. At day 7, optical microscopy revealed a more plentiful cellularity in the granulation tissue compared with the dermal regeneration matrix. The immunohistochemical process highlighted vascular and lymphatic cells in both groups. After 14 days a high grade of fibrosis was noticeable in the non-treated group. At day 21, both lymphatic and vascular endothelial cells were better developed in the group with a dermal matrix application. At day 28, lymphatic endothelial cells had organized themselves, engineering the pseudocylindrical structure better disposed in the ADM group than in the control group, and the lymphatic cells were detectable inside the vessels’ lumen in this group. Conclusion: This study has made it possible to demonstrate the absolute importance of an ADM in proper wound healing and has shown better definition of both the qualitative and quantitative aspects of lymphangiogenesis compared to the second intention healing. A major grade of organization of the extracellular matrix and a minor grade of fibrosclerosis in ADM allowed a well-structured morphologic and functional development of the endothelial and lymphatic vascular structures. This study hopes to represent a clinical basis for a wider use of ADM in lesions where lymphatic complications are common.

KEY WORDS

Acellular dermal matrix - INTEGRA® - lymphangiogenesis
 

  • REFERENCES

  • 1 Goshtasby PH, Chami RG, Johnson RM. A novel approach to the management of pyoderma gangrenosum complicating reduction mammaplasty. Aesthet Surg J 2010; 30: 186-93
    CrossrefPubMedGoogle Scholar
  • 2 Aquilina D, Darmanin FX, Briffa J, Gatt D. Chest wall reconstruction using an omental flap and Integra. J Plast Reconstr Aesthet Surg 2009; 62: e200-2
    CrossrefPubMedGoogle Scholar
  • 3 Palao R, Gómez P, Huguet P. Burned breast reconstructive surgery with Integra dermal regeneration template. Br J Plast Surg 2003; 56: 252-9
    CrossrefPubMedGoogle Scholar
  • 4 Tsoutsos D, Stratigos A, Gravvanis A, Zapandioti P, Kakagia D. Burned breast reconstruction by expanded artificial dermal substitute. J Burn Care Res 2007; 28: 530-2
    CrossrefPubMedGoogle Scholar
  • 5 Khan MA, Ali SN, Farid M, Pancholi M, Rayatt S, Yap LH. Use of dermal regeneration template (Integra) for reconstruction of full-thickness complex oncologic scalp defects. J Craniofac Surg 2010; 21: 905-9
    CrossrefPubMedGoogle Scholar
  • 6 Burd A, Wong PS. One-stage Integra reconstruction in head and neck defects. J Plast Reconstr Aesthet Surg 2010; 63: 404-9
    CrossrefPubMedGoogle Scholar
  • 7 Valdatta L, Maggiulli F, Scamoni S, Pellegatta I, Cherubino M. Reconstructive management of degloving trauma of male external genitalia using dermal regeneration template: A case report. J Plast Reconstr Aesthet Surg 2014; 67: 264-6
    CrossrefPubMedGoogle Scholar
  • 8 Dantzer E, Queruel P, Salinier L, Palmier B, Quinot JF. Integra, a new surgical alternative for the treatment of massive burns. Clinical evaluation of acute and reconstructive surgery: 39 cases. Ann Chir Plast Esthet 2001; 46: 173-89
    PubMedGoogle Scholar
  • 9 Lee LF, Porch JV, Spenler W, Garner WL. Integra in lower extremity reconstruction after burn injury. Plast Reconstr Surg 2008; 121: 1256-62
    CrossrefPubMedGoogle Scholar
  • 10 Rindler R, Garcia C. Letter: The use of a dermal substitute and thin skin grafts in the cure of "complex" leg ulcers. Dermatol Surg 2010; 36: 426
    PubMedGoogle Scholar
  • 11 Abai B, Thayer D, Glat PM. The use of a dermal regeneration template (Integra) for acute resurfacing and reconstruction of defects created by excision of giant hairy nevi. Plast Reconstr Surg 2004; 114: 162-8
    PubMedGoogle Scholar
  • 12 Chalmers RL, Smock E, Geh JL. Experience of Integra(®) in cancer reconstructive surgery. J Plast Reconstr Aesthet Surg 2010; 63: 2081-90
    CrossrefPubMedGoogle Scholar
  • 13 Cherubino M, Scamoni S, Pellegatta I, Maggiulli F, Minuti A, Valdatta L. Massive de-gloving thigh injury treated by vacuum therapy, dermal regeneration matrix and lipografting. Afr J Paediatr Surg 2013; 10: 386-9
    CrossrefPubMedGoogle Scholar
  • 14 Moiemen NS, Vlachou E, Staiano JJ, Thawy Y, Frame JD. Reconstructive surgery with Integra dermal regeneration template: Histologic study, clinical evaluation, and current practice. Plast Reconstr Surg 2006; 117 (Suppl. 07) Suppl 160S-74
    CrossrefPubMedGoogle Scholar
  • 15 Unglaub F, Ulrich D, Pallua N. Reconstructive surgery using an artificial dermis (Integra): Results with 19 grafts. Zentralbl Chir 2005; 130: 157-61
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Haertsch P. Reconstructive surgery using an artificial dermis (Integra). Br J Plast Surg 2002; 55: 362-3
    PubMedGoogle Scholar
  • 17 Moiemen NS, Staiano JJ, Ojeh NO, Thway Y, Frame JD. Reconstructive surgery with a dermal regeneration template: Clinical and histologic study. Plast Reconstr Surg 2001; 108: 93-103
    CrossrefPubMedGoogle Scholar
  • 18 Xie WG, Tan H, Zhao CL, Wang H. The histological changes and the revascularization process in the grafted dermal substitutes. Zhonghua Shao Shang Za Zhi 2005; 21: 37-9
    PubMedGoogle Scholar
  • 19 Moiemen NS, Vlachou E, Staiano JJ, Thawy Y, Frame JD. Reconstructive surgery with Integra dermal regeneration template: Histologic study, clinical evaluation, and current practice. Plast Reconstr Surg 2006; 117 (Suppl. 07) Suppl 160S-74
    CrossrefPubMedGoogle Scholar
  • 20 Kim KE, Sung HK, Koh GY. Lymphatic development in mouse small intestine. Dev Dyn 2007; 236: 2020-5
    CrossrefPubMedGoogle Scholar
  • 21 Zhou Q, Wood R, Schwarz EM, Wang YJ, Xing L. Near-infrared lymphatic imaging demonstrates the dynamics of lymph flow and lymphangiogenesis during the acute versus chronic phases of arthritis in mice. Arthritis Rheum 2010; 62: 1881-9
    PubMedGoogle Scholar
  • 22 Wong AK, Schonmeyr B, Singh P, Carlson DL, Li S, Mehrara BJ. Histologic analysis of angiogenesis and lymphangiogenesis in acellular human dermis. Plast Reconstr Surg 2008; 121: 1144-52
    CrossrefPubMedGoogle Scholar
  • 23 Cross SE, Naylor IL, Coleman RA, Teo TC. An experimental model to investigate the dynamics of wound contraction. Br J Plast Surg 1995; 48: 189-97
    CrossrefPubMedGoogle Scholar
  • 24 Dorsett-Martin WA. Rat models of skin wound healing: A review. Wound Repair Regen 2004; 12: 591-9
    CrossrefPubMedGoogle Scholar
  • 25 Herlin C, Louhaem D, Bigorre M, Dimeglio A, Captier G. Use of Integra in a paediatric upper extremity degloving injury. J Hand Surg Eur Vol 2007; 32: 179-84
    CrossrefPubMedGoogle Scholar
  • 26 Chalmers RL, Smock E, Geh JL. Experience of Integra(®) in cancer reconstructive surgery. J Plast Reconstr Aesthet Surg 2010; 63: 2081-90
    CrossrefPubMedGoogle Scholar
  • 27 Popescu S, Ghetu N, Grosu O, Nastasa M, Pieptu D. Integra - A therapeutic alternative in reconstructive surgery. Our first experience. Chirurgia (Bucur) 2007; 102: 197-204
    PubMedGoogle Scholar
  • 28 Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): Results with 39 grafts. Br J Plast Surg 2001; 54: 659-64
    CrossrefPubMedGoogle Scholar
  • 29 Wolter TP, Noah EM, Pallua N. The use of Integra in an upper extremity avulsion injury. Br J Plast Surg 2005; 58: 416-8
    CrossrefPubMedGoogle Scholar
  • 30 Gröger M, Loewe R, Holnthoner W, Embacher R, Pillinger M, Herron GS. et al. IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J Immunol 2004; 173: 7161-9
    CrossrefPubMedGoogle Scholar
  • 31 Castro EC, Galambos C. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations - A proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Pediatr Dev Pathol 2009; 12: 187-94
    CrossrefPubMedGoogle Scholar
  • 32 McGovern S, Pan J, Oliver G, Cutz E, Yeger H. The role of hypoxia and neurogenic genes (Mash-1 and Prox-1) in the developmental programming and maturation of pulmonary neuroendocrine cells in fetal mouse lung. Lab Invest 2010; 90: 180-95
    Google Scholar
  • 33 Petrova TV, Mäkinen T, Mäkelä TP, Saarela J, Virtanen I, Ferrell RE. et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 2002; 21: 4593-9
    CrossrefPubMedGoogle Scholar
  • 34 Rodriguez-Niedenführ M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI. et al. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl) 2001; 204: 399-406
    CrossrefPubMedGoogle Scholar
  • 35 Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J. et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 16: 1271-3
    CrossrefPubMedGoogle Scholar
  • 36 Park S, DiMaio TA, Scheef EA, Sorenson CM, Sheibani N. PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. Am J Physiol Cell Physiol 2010; 299: C1468-84
    CrossrefPubMedGoogle Scholar
  • 37 DiMaio TA, Sheibani N. PECAM-1 isoform-specific functions in PECAM-1-deficient brain microvascular endothelial cells. Microvasc Res 2008; 75: 188-201
    CrossrefPubMedGoogle Scholar
  • 38 Woodfin A, Voisin MB, Nourshargh S. PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007; 27: 2514-23
    CrossrefPubMedGoogle Scholar
  • 39 Campitiello E, Della Corte A, Fattopace A, D’Acunzi D, Canonico S. The use of artificial dermis in the treatment of chronic and acute wounds: Regeneration of dermis and wound healing. Acta Biomed 2005; 76 Suppl (Suppl. 01) 69-71
    PubMedGoogle Scholar
  • 40 Cole PD, Stal D, Sharabi SE, Hicks J, Hollier Jr LH. A comparative, long-term assessment of four soft tissue substitutes. Aesthet Surg J 2011; 31: 674-81
    CrossrefPubMedGoogle Scholar
  • 41 Upadhyaya M, Orford JE, Smith N, Barker A, Gollow I. Incorporation of Integra in tissue defects: A pilot study in the rat model. Pediatr Surg Int 2007; 23: 669-73
    CrossrefPubMedGoogle Scholar
  • 42 Greenwood J, Amjadi M, Dearman B, Mackie I. Real-time demonstration of split skin graft inosculation and Integra dermal matrix neovascularization using confocal laser scanning microscopy. Eplasty 2009; 9: e33
    PubMedGoogle Scholar
  • 43 Xie WG, Tan H, Zhao CL, Wang H. The histological changes and the revascularization process in the grafted dermal substitutes. Zhonghua Shao Shang Za Zhi 2005; 21: 37-9
    PubMedGoogle Scholar
  • 44 Shimamura K, Nakatani T, Ueda A, Sugama J, Okuwa M. Relationship between lymphangiogenesis and exudates during the wound-healing process of mouse skin full-thickness wound. Wound Repair Regen 2009; 17: 598-605
    CrossrefPubMedGoogle Scholar
  • 45 Ji RC, Miura M, Qu P, Kato S. Expression of VEGFR-3 and 5’-nase in regenerating lymphatic vessels of the cutaneous wound healing. Microsc Res Tech 2004; 64: 279-86
    CrossrefPubMedGoogle Scholar
  • 46 Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000; 156: 1499-504
    CrossrefPubMedGoogle Scholar
  • 47 Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D’Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007; 170: 1178-91
    CrossrefPubMedGoogle Scholar
  • 48 Mallon EC, Ryan TJ. Lymphedema and wound healing. Clin Dermatol 1994; 12: 89-93
    CrossrefPubMedGoogle Scholar
  • 49 King WW, Lam PK, Liew CT, Ho WS, Li AK. Evaluation of artificial skin (Integra) in a rodent model. Burns 1997; 23 (Suppl. 01) Suppl S30-2
    CrossrefPubMedGoogle Scholar
  • 50 Druecke D, Lamme EN, Hermann S, Pieper J, May PS, Steinau HU. et al. Modulation of scar tissue formation using different dermal regeneration templates in the treatment of experimental full-thickness wounds. Wound Repair Regen 2004; 12: 518-27
    CrossrefPubMedGoogle Scholar
  • 51 Vaillant L, Tauveron V. Primary lymphedema of limbs. Presse Med 2010; 39: 1279-86
    CrossrefPubMedGoogle Scholar
  • 52 Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002; 1: 219-27
    CrossrefPubMedGoogle Scholar
  • 53 Liersch R, Detmar M. Lymphangiogenesis in development and disease. Thromb Haemost 2007; 98: 304-10
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Ji RC. Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 2005; 20: 155-75
    PubMedGoogle Scholar
  • 55 Collier M. The use of advanced biological and tissue-engineered wound products. Nurs Stand 2006; 21: 68-70 , 72
    CrossrefPubMedGoogle Scholar